![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29607-29612, October 15, 1999
§,
,
,
,
From the
CNR Centro Studi Biomembrane, Dipartimento
Scienze Biomediche Sperimentali, viale G. Colombo 3, 35121 Padova,
Italy, ¶ Istituto Superiore di Sanità, Dipartimento di
Ematologia ed Oncologia, viale Regina Elena 299, 00161 Roma, Italy,
** Laboratorio di Biochimica e Biologia Molecolare, Dipartimento Scienze
Chimiche, Facoltà di Scienze M.F.N., Università di Catania,
viale A. Doria 6, 95125 Catania, Italy, and
§§ Department of Molecular Pharmacology, Albert
Einstein College of Medicine, Bronx, New York, New York 10461
| |
ABSTRACT |
|---|
|
|
|---|
Mitochondrial porin, or
voltage-dependent anion channel, is a pore-forming protein
first discovered in the outer mitochondrial membrane. Later
investigations have provided indications for its presence also in other
cellular membranes, including the plasma membrane, and in caveolae.
This extra-mitochondrial localization is debated and no clear-cut
conclusion has been reached up to now. In this work, we used
biochemical and electrophysiological techniques to detect and
characterize porin within isolated caveolae and caveolae-like domains
(low density Triton-insoluble fractions). A new procedure was used to
isolate porin from plasma membrane. The outer surface of cultured CEM
cells was biotinylated by an impermeable reagent. Low density
Triton-insoluble fractions were prepared from the labeled cells and
used as starting material to purify a biotinylated protein with the
same electrophoretic mobility and immunoreactivity of mitochondrial
porin. In planar bilayers, the porin from these sources formed slightly
anion-selective pores with properties indistinguishable from those of
mitochondrial porin. This work thus provides a strong indication of the
presence of porin in the plasma membrane, and specifically in caveolae and caveolae-like domains.
Caveolae are plasma membrane organelles, characterized by a low
solubility in Triton X-100, where specific lipid and protein components
are subcompartmentalized. They have been proposed to function in
transcytosis, potocytosis (involving GPI-linked receptors and (an)
unknown anion carrier(s) or pore(s)), and signal transduction (1-3).
Caveolins, a family of integral membrane proteins, are the structural
proteins of caveolae; they form a "scaffold" on which a variety of
signaling molecules are organized in complexes (3). In cells not
expressing caveolin, analogous microdomains are formed by association
of sphingolipids and cholesterol. They have been referred to as DIGs
(detergent-insoluble glycolipid-enriched complexes) (4) or, as in this
study, as low density Triton-insoluble complexes
(LDTIs)1 (5). We have
previously established a reliable procedure to isolate caveolae and
LDTI from tissues or cultured cells (6), which allowed us to compile a
partial catalogue of caveolar proteins (7). In the mouse lung
preparation, >98% of generic plasma membrane protein markers and
>99.6% of organelle (Golgi, lysosomes, endoplasmic reticulum) markers
were excluded, whereas >85% of caveolin was retained. Porin was
tentatively identified as a caveolar component by microsequencing an
SDS-PAGE band (7).
Porin, or VDAC, is an integral membrane protein of about 35 kDa forming
a pore permeable to solutes of molecular mass <2 kDa in the outer
mitochondrial membrane (8, 9). Its most relevant biophysical properties
upon reconstitution in planar bilayers include a maximal conductance of
about 4.5 nanoSiemens in 1 M KCl, a symmetrical
voltage dependence leading to closures at potentials higher than about
±20 mV, the presence of many subconductance levels, a slight
selectivity for anions in the fully open state, and a variable kinetic
behavior with both slow and fast gating modes (10). The lack of porin
in muscle biopsies has been associated with an inherited fatal
encephalomyopathy (11). In higher eukaryotes, the existence of multiple
genes (12) and transcripts (13) has recently been established, but
little is known about the role(s) and subcellular compartmentalization
of porin isoforms and about a possible modulation of the pore, which
was believed until recently (10), to be unable to close completely. In
1989, Thinnes and co-workers (14, 15) reported the presence of the
porin isoform 31-HL (or HVDAC1) in the plasma membrane of human B
lymphocytes. The presence of VDAC in the plasma membrane of at least
some cell types has since been supported (16, 17), but the finding has been disputed (18) and the issue remains undecided. The aim of this
work was thus to establish whether porin is present in the plasma
membrane, and specifically in caveolae or caveolae-related domains, of
hematopoietic and brain cells. This question is of high biological
relevance, because the main recognized task of porin is to create a
large, rather unspecific, channel, apparently incompatible with plasma
membrane function.
Isolation of Caveolae, LDTI, and Mitochondria--
Caveolae-rich
fractions were prepared from organs (rat heart, bovine brain and dog
lung) using a modification of a procedure that has previously been
developed for lung (7). 0.4-0.5 g (wet weight) organ tissue was
snap-frozen and ground. Each sample was resuspended in 3 ml of 1%
Triton X-100 MBS (25 mM Mes, pH 6.5, 0.15 M
NaCl) or in 0.5 M Na2CO3, pH 11 (detergent-free procedure, see Ref. 19), and homogenized. A quarter of
the tissue homogenate was adjusted to 40% sucrose, placed at the
bottom of an ultracentrifuge tube and overlaid with 30 and 5% sucrose
buffered with MBS or Na2CO3, to form a
three-step discontinuous gradient. After centrifugation (14-17 h) in a
SW60 rotor at 45,000 rpm, 4 °C, a sharp band (LDTI) was collected
between the 5 and 30% sucrose layers. Alternatively, 12 fractions were
collected from the top of the centrifuge tube and analyzed. Normal
hematopoietic cells (granulocytes, lymphocytes, monocytes) from human
peripheral blood and neoplastic counterparts (CEM, UT-7, HL-60) were
fractionated, and LDTI was obtained by similar procedures (5).
Mitochondria were isolated by standard procedures.
Porin Purification from Caveolae and LDTI--
1 ml of caveolae
or LDTI in MBS (about 10 mg of protein) was solubilized for 30 min at
4 °C with 1 ml of 3% Triton X-100, 10 mM Tris-HCl, pH
7.0, 1 mM EDTA. The suspension was then spun down and the
supernatant (ET1) recovered; the pellet was again solubilized with 1 ml
of 10% Triton X-100, 10 mM Tris-HCl, pH 7.0, 1 mM EDTA. Solubilization and centrifugation yielded
supernatant ET2. Fractions ET1 and ET2 were loaded onto separate
hydroxylapatite/celite (Bio-Rad, Serva) 2:1 dry columns (0.3 g) (20).
Elution was performed with solubilization medium. Three fractions were
collected, corresponding to the unretarded material and to the
following 0.6-ml portions.
Purification of Biotinylated Plasma Membrane Porin--
CEM
cells (an established T lymphoid-like cell line) were washed three
times with phosphate-buffered saline without calcium and magnesium and
incubated with NHS-SS-Biotin (Pierce) (0.5 mg/ml; 30 min, 4 °C). The
cells were then processed to obtain the LDTI fraction. The porin
purification procedure described above was performed on this material.
The fraction containing the HTP/celite pass-through was incubated for
4 h with an equal volume of swollen immobilized
streptavidin-agarose (Pierce), pre-equilibrated with solubilization
medium. After two washing steps, the agarose was incubated with 0.1 M dithioerythritol for 30 min. After centrifugation, the
supernatant was analyzed by SDS-PAGE.
Western Blotting Analysis and Immunoprecipitation
Experiments--
Total cell lysate was obtained by lysis (30 min at
4 °C) with 0.5 ml of 150 mM NaCl, 10 mM
Tris, pH 7.4, 1% Nonidet P-40, 10% glycerol plus protease inhibitors
(aprotinin, 1 µg/ml; pepstatin A, 1 µg/ml; leupeptin, 1 µg/ml;
phenylmethylsulfonyl fluoride, 100 µg/ml), followed by
centrifugation. Proteins were resolved by SDS-PAGE and blotted to
nitrocellulose. The primary antibodies used are specified where
appropriate; they were from commercial sources unless specified.
Anti-porin Abs were used at a dilution of 1:1,000, and
anti-Pi Abs at 1:40,000. Blots were developed (secondary
antibody-horseradish peroxidase, Life Technologies, Inc.) using a
chemiluminescence kit. The immunoprecipitation was performed by mixing
20 µg of LDTI domains obtained from NHS-SS-Biotin-treated CEM cells,
precleared with 30 µl of a 50% protein A/G-agarose suspension
(Pierce), and 1 µl of nonimmune serum in 0.5 ml of lysis buffer for
1 h at 4 °C. 0.5 µg/ml anti-CD4 or 1 µg/ml anti-PKC Planar Lipid Bilayer Experiments--
Experiments were conducted
as has previously been described (21). Purified asolectin (Sigma),
phosphatidylethanolamine, or diphytanoylphosphatidylcholine (Avanti)
membranes were prepared by painting a decane solution across a hole in
a Teflon film separating cis and trans chambers. The experimental
medium was 0.1, 0.5, or 1 M KCl plus 0.1 mM
CaCl2, 20 mM Hepes, pH 7.2. Voltages of the cis
side (where porin was added) are reported. Current (cations) flowing
from the cis to the trans compartment is considered positive and
plotted upward.
We tested caveolae and mitochondria isolated from different organs
(bovine brain, rat heart, and dog lung) for the presence of caveolin 1 or 3, of a mitochondrial marker, namely the phosphate carrier
(Pi), and of porin. The anti-porin antibodies were raised either against the whole purified porin from bovine heart mitochondria or against a synthetic peptide mimicking the N-terminal end of HVDAC1
(22). These antibodies did not show any cross-reactivity with sequences
from HVDAC2 (23) nor with any cellular protein other than
HVDAC1.2 Fig.
1A shows the Western blots
obtained applying these antibodies to purified caveolae or
mitochondria. Although caveolin was detected in caveolae and the
phosphate carrier in mitochondria, porin was present in both fractions.
The presence of caveolae in nervous tissue has been recently
established (24, 25). Furthermore a procedure for the purification of
caveolae using Na2CO3 and no detergent (19) was
compared with the usual Triton isolation procedure. Protein from
sucrose gradient fractionation were resolved by SDS-PAGE and stained in
parallel with antibodies against porin, caveolin, and lyn (Fig.
1B). Lyn and lck are Src-family tyrosine kinases selectively
recovered in LDTI from human leukemia cell lines and granulocytes (5).
Porin distribution exactly matched those of caveolin and lyn also in
the detergent-free procedure.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Abs
were then added to the sample, and kept overnight at 4 °C, followed
by incubation with pre-washed beads (40 µl), 1 h at 4 °C. The
beads were washed 4 times, resuspended in 30 µl of sample buffer,
boiled, and centrifuged. The supernatant was run on SDS-PAGE and
immunodetected with anti-CD4 or with anti-PKC
.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (14K):
[in a new window]
Fig. 1.
Porin detection in caveolae or LDTI from
various tissues and cell lines. A, 20 µg of protein
from bovine brain, rat heart, and dog lung caveolae were analyzed by
Western blotting for porin, caveolin, and the mitochondrial phosphate
carrier (Pi). Brain, heart and lung caveolae were incubated
with polyclonal anti-caveolin, monoclonal anti-caveolin 3, and
monoclonal anti-caveolin 1, respectively. Porin and Pi were
assayed with polyclonal Abs. Brain, heart,
lung, caveolae from the respective organs; mit.
brain, brain mitochondria. B, bovine brain was
treated with 1% Triton X-100 or 0.5 M
Na2CO3 and subjected to a discontinuous 5-40%
sucrose density gradient centrifugation. Twelve fractions were
collected. Fractions containing 25 µg of protein were analyzed by
Western blotting with polyclonal Abs against lyn (a Src protein),
mitochondrial porin, or caveolin. C, LDTI (L)
were obtained by the Triton procedure from human hematopoietic
neoplastic (CEM, UT-7, HL-60) and normal (lymphocytes, granulocytes,
monocytes) cells. 20-µg fractions from LDTI (L) and total
cell lysate (T) were separated, blotted, and immunostained
with polyclonal Abs anti-Pi, anti-porin and anti-lyn or
lck.
Several studies have pointed to the existence of porin in the cellular membrane of B and T lymphocytes. Thus, we assessed the presence of plasma membrane porin in hematopoietic cells, in which glycolipid-enriched domains (LDTI) likely represent the caveolae counterpart (3, 5, 27). Neoplastic (T-lymphoid (CEM), megakaryocytic (UT-7), promyelocytic (HL-60)) and normal (lymphocytes, granulocytes, monocytes) human hematopoietic cells were screened for porin expression (Fig. 1C). In every cell line the comparison between total cell protein extracts (T) and LDTI domains (L) indicated porin enrichment in the latter. The only exceptions were granulocytes (Fig. 1C) and red blood cells (not shown), in which porin was absent. This observation suggests that porin expression in the plasma membrane is regulated and possibly tissue- or cell-specific. The absence of porin in granulocyte LDTI further indicates that LDTI-associated porin in other cell types was not just a contaminant. Hematopoietic LDTI resident proteins, lck and lyn (5), were also detected. Our mitochondrial marker, the phosphate carrier (Pi), was absent from LDTI domains.
The functionality of porin in caveolae was assayed by incorporation of
brain caveolae and CEM cell LDTI, prepared by the Triton method, into
planar bilayers. VDAC-like channel activity (Fig. 2) was observed in 11 of 18 experiments
with brain caveolae and in 22 of 27 experiments with CEM LDTI. These
pores displayed single channel conductances matching the range of
mitochondrial porin that were proportional to the salt concentration
(at least up to 1 M KCl). They showed also voltage-induced
closure at both positive and negative potentials (Fig. 2, A
and B), both slow and fast kinetic modes, and both cation-
and anion-selective conductance states (Fig. 2,
B-D). These channel characteristics were in
agreement with the known properties of VDAC. Panel B, taken
from an experiment in 390:100 (cis:trans) mM KCl,
illustrates a "memory effect". A channel in a high conductance,
anion-selective state (negative current flowing) at zero applied
potential, closed partially to a cation-selective substate upon
application of
40 mV, and remained cation-selective upon returning to
zero potential (positive current flowing). We routinely observed
channel gating, including transitions between states of opposite
selectivity, at 0 applied voltage (Fig. 2C), a behavior
exhibited also by mitochondrial
porin.3
|
We next isolated porin from bovine brain caveolae. The usual porin
purification procedure (20) was first attempted on caveolae, but porin
from this source turned out to be poorly soluble in 3% Triton X-100.
We thus used a 10% Triton X-100 solution, which was more effective for
porin solubilization. Elution from the HTP/celite column was performed
with 3% Triton X-100. An SDS-PAGE of protein fractions obtained during
the purification is shown in Fig. 3. The
procedure yielded a single protein band of about 35 kDa (lanes
3 and 4), co-migrating with porin purified from bovine
heart mitochondria (lane Po). This porin preparation
exhibited a behavior indistinguishable from that of mitochondrial porin in planar lipid bilayer experiments (not shown).
|
In control experiments, we subjected mitochondria purified from bovine heart and rat liver to sucrose density centrifugation according to the protocol used for the isolation of caveolae. In these experiments, we observed that the mitochondrial porin could band between the 5 and 30% sucrose layers (data not shown). This result was indeed relevant, because porin has been demonstrated to be associated with sterol molecules both in Neurospora crassa (50) and in mammals (31). It posed the question of whether our caveolae preparations might be contaminated by mitochondrial proteins. We mentioned the absence of Pi carrier in LDTI; in addition, Western blots performed with Abs against four different rat liver mitochondrial outer membrane proteins did not show any partitioning in the LTDI fraction in similar experiments (see Fig. 5 in Ref. 26). These results might mean that porin may exist in mitochondrial microdomains excluding most mitochondrial proteins but having the same density as caveolae or LTDI.
To rule out the possibility that the porin in caveolae might be just
due to a contamination, we modified our purification procedure
including a preliminary biotinylation step with an impermeable reagent:
this was aimed at selecting proteins with domains exposed on the
surface of the cell. We used NHS-SS-Biotin, a hydrophilic reporter
containing an S-S bridge between the reactive moiety and biotin, to
label CEM cells. To assess the impermeability of the cellular membrane
to NHS-SS-Biotin, two assays were performed: (i) dye exclusion
following biotinylation, to test cell integrity, and (ii)
immunoprecipitation of plasma membrane marker proteins, CD4 and PKC
,
followed by streptavidin staining, to rule out the accessibility of the
inner side of the plasma membrane to our reporter molecule. CD4 is a
transmembrane protein localized in lymphocyte LDTI (5), containing
hydrophilic domains exposed outside the cell. PKC
is a plasma
membrane protein, which does not show any hydrophilic moiety on the
outer side of the membrane (27). PKC
, CD4, and porin co-partitioned
in the sucrose density fractions containing LDTI (Fig.
4A). After biotinylation, CEM cells were assayed for Trypan blue exclusion. 99% of biotinylated CEM
cells were viable (not shown). They were processed to obtain LDTI. 20 µg of protein was immunoprecipitated with Abs anti-CD4 or
anti-PKC
, and the proteins were revealed by immunostaining with the
same antibodies or with streptavidin (Fig. 4B). Only CD4 was
detectable by streptavidin, indicating that only protein domains
exposed to the outer side of the plasma membrane were biotinylated.
|
Biotinylated LTDI from CEM cells were subjected to the porin
purification procedure described above. It resulted in a doublet of
very close bands, as shown in Fig.
5A. These two bands represent modified (lower mobility band) and unmodified (higher mobility band)
porin molecules, as established by comparative staining with anti-porin
Ab and streptavidin-horseradish peroxidase conjugate (not shown). The
reason for the partial porin unavailability to NHS-SS-biotin labeling
is unclear. It might have been due to technical reasons
(i.e. labeling conditions) or to the protein transmembrane disposition; it is well known that porin is deeply embedded in the
phospholipid bilayer (28), and thus poorly accessible to bulky
hydrophilic molecules. For our purposes the matter is not highly
relevant, because our goal was to isolate only NHS-SS-biotinylated porin molecules, certainly originating from caveolar domains of the
plasma membrane. The application of these proteins to immobilized streptavidin-agarose, followed by elution with dithioerythritol , resulted in a single protein band (Fig. 5A). The purified
protein was identified as porin by positive staining in Western blots with polyclonal Abs versus purified bovine heart
mitochondrial porin or with monoclonal Abs versus a
synthetic peptide reproducing the N terminus of HVDAC1 (22, 23). This
result demonstrates the purification of porin molecules labeled by
NHS-SS-biotin, coming from the plasma membrane of intact CEM cells.
|
Upon incorporation of this plasma membrane porin into planar bilayers
we observed channel activity with properties very similar to those of
mitochondrial porin as well as of the other preparations mentioned
above. Again, the pores displayed the typical functional features of
mitochondrial porin such as the appropriate conductance, voltage
dependence, slow and fast kinetics, anion- and cation-selective conductance states (Fig. 6).
|
We furthermore detected, by patch-clamp in the excised patch
configuration on the plasma membrane of CEM cells, an anion-selective channel with characteristics similar to those of the isolated caveolar
porin (not shown). The channel is similar to the "maxi-chloride channel" observed in the plasma membrane of several cell types (29,
30).
| |
DISCUSSION |
|---|
|
|
|---|
Eukaryotic porin is a much studied but still incompletely understood integral membrane protein very abundant in mitochondria, which forms large pores when reconstituted in artificial membranes (8, 9). Porin isoforms have been identified in humans and their expression in most tissues reported (13). Porin has widely been considered to be localized exclusively in the outer membrane and at contact sites of mitochondria. However, since the first work by Thinnes et al. (14), several studies have reported the presence of VDAC in the plasma membrane of lymphocytes (15, 17), respiratory epithelium cells, and astrocytes (16). Its presence in the sarcoplasmic reticulum (31, 32) and endosomes (33) has also been reported. It is particularly relevant for this paper that the major isoform, 31HL/HVDAC1, has been identified by partial sequencing in preparations of caveolae from lung epithelium (7). The notion that VDAC may be present in the plasma membrane has been challenged by Yu et al. (18). These authors introduced into three cDNAs for VDAC isoforms sequences encoding for known epitopes, recognized by monoclonal antibodies. Cultured cells were transfected with these constructs, and biochemical, immunofluorescence and immuno-EM techniques were used to localize the products. All three porin isoforms appeared to be located exclusively in mitochondria. Reports associating VDAC with the plasma membrane were tentatively ascribed to nonspecific reaction of antibodies or, in the case of caveolae, to the binding of solubilized VDAC to caveolar components during the preparative procedures. The main aim of this work was to clarify this issue.
Labeling of the intact outer face of cultured plasma membrane was used to discriminate plasma membrane protein from other molecules coming from inside the cell. We then applied on the biotinylated caveolar material a mixed purification procedure. The starting material was LTDI (a caveolae-like fraction); in this way we could minimize contamination by most intracellular proteins (19). The first purification step is very selective for porin molecules (20). Next, streptavidin-agarose selected only those porin molecules genuinely coming from the plasma membrane because only these were biotynilated. We are thus confident that the porin molecules purified by this procedure originated from caveolar microdomains in the plasma membrane. We cannot rule out the possibility that porin is present also in other districts of the plasma membrane; our results indicate that it is present in caveolae and caveolae-like material where it is strongly enriched.
The next main point of our work was the identification of porin purified from caveolae. Porin purified from caveolae looked like the same polypeptide isolated from mitochondria. This was shown both by molecular data (identical immunological reactivity, identical chromatographic behavior) and by electrophysiological analysis. When incorporated in planar bilayers, porin from mitochondria and porin purified from caveolae showed indistinguishable properties. The human polypeptide indicated in literature as porin 31HL, HVDAC1, or porin isoform 1 seems thus able to be incorporated both into the plasma membrane and into the mitochondrial outer membrane. This opens stimulating questions about the physiological role of porin in the plasma membrane and about the mechanisms of targeting directing the same polypeptide to two distinct subcellular compartments.
The function of porin in the plasma membrane is unknown. It might serve as the conduit for solute release from potocytotic vesicles. Mitochondrial porin has been shown to catalyze the translocation of DNA through artificial membranes (34), and it might perform a similar function in caveolae. Clearly, the porin in the plasma membrane must generally be in a nonconductive state to avoid dissipation of vital ion gradients. The channel should thus be tightly regulated. Several patch clamp studies have reported a porin-like plasma membrane channel (the "maxi-chloride channel") (16, 29, 30) that is normally closed and opens up only after disruption of the membrane (excised patch mode). We have also observed such a channel in patch-clamp experiments on CEM cells. Following internalization of the caveolae the porin could be open without risking any ionic unbalance.
A second question concerns VDAC targeting to different membranes. Porin insertion into membranes does not require any protein pre-sequence (35). Very few examples of proteins targeted both to mitochondria and to another cellular district have been reported. They showed alternative splicing conferring specific target sequences to expressed proteins (36). For porin, the only hint comes from the recent discovery in the Drosophila melanogaster gene of alternative transcripts differing only in the 5'-UTR region of the mature mRNAs (37). Neither of these alternative exons confers to the protein any polypeptide pre-sequence. Whether a similar situation is present also in mammals is unknown, but this hypothesis cannot be ruled out. If it were true, how could different mRNAs coding for the same protein be targeted to different compartments? UTR regions of mRNA have been proposed to be responsible for specific mRNA intracellular localization, a tool for the cell to exert a local translational control (38, 39). Recently evidence was provided for a functional involvement of the 5' end of oskar mRNA, a factor involved in the development of D. melanogaster, in the regulation of the mRNA translation (40). Lithgow et al. (38) have reviewed the transport of mRNAs to ribosomes close to target subcellular compartments. One can thus hypothesize that different porin 5'-UTRs could contain sequences involved in the targeting of transcripts to localized ribosome pools. This hypothesis is compatible with the data by Yu et al. (18), which did not rule out a differentiated targeting of transcripts containing alternative 5'-untranslated sequences.
A second hypothesis on the plasma membrane targeting of porin relies on
its affinity for cholesterol. Porin might be present in caveolae and
caveolae-like domains simply because these are stations on the way to
its final destination(s). Porin binds cholesterol (28, 41, 42), and
caveolae are especially rich in cholesterol, playing an important role
in its traffic (43). Thus an alternative working hypothesis may be that
porin mRNA(s) are translated in the cytosol, and some molecules are
transported to the caveolar region by means of caveolin-cholesterol
complexes. Next, porin could be relocated to subcellular compartments
through the intracellular cholesterol transport routes.
| |
ACKNOWLEDGEMENTS |
|---|
We thank F. Thinnes and F. Palmieri for generous gifts of noncommercial antibodies.
| |
FOOTNOTES |
|---|
* This work was supported in part by Telethon-Italy Grants A44 and A59 (to M. Z.), Grant 711 (to V. D. P.), and a fellowship (to G. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Current address: Dept. of Physiology, Semmelweis Medical University, Puskin u. 9, H-1088 Budapest, Hungary.
Supported by a post-doctoral fellowship from the University of Padova.

Funding received from MURST-COFIN 98 and Consiglio Nazionale
delle Ricerche. To whom correspondence should be addressed: Tel.: 39-095-337195; Fax: 39-095-337036; E-mail:
vdpbiofa@mbox.unict.it.
2 V. De Pinto, unpublished observations.
3 G. Bàthori, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
LDTI, low density
Triton-insoluble fraction;
NHS-SS-biotin, sulfosuccinimidyl-2-[biotin-amido]-ethyl-1,3-dithiopropionate;
VDAC, voltage-dependent anion channel;
Mes, 4-morpholineethanesulfonic acid;
PAGE, polyacrylamide gel
electrophoresis;
Abs, antibodies;
PKC
, protein kinase C
;
UTR, untranslated region.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Palade, G. E. (1953) J. Appl. Physiol. 24, 1424-1429 |
| 2. | Parton, R. G. (1996) Curr. Opin. Cell Biol. 8, 542-548[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Okamoto, T.,
Schlegel, A.,
Scherer, P.,
and Lisanti, M. P.
(1998)
J. Biol. Chem.
273,
5419-5422 |
| 4. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Parolini, I.,
Sargiacomo, M.,
Lisanti, M. P.,
and Peschle, C.
(1996)
Blood
87,
3783-3794 |
| 6. |
Sargiacomo, M.,
Sudol, M.,
Tang, Z. L.,
and Lisanti, M. P.
(1993)
J. Cell Biol.
122,
789-807 |
| 7. |
Lisanti, M. P.,
Scherer, P.,
Vidugiriene, J.,
Tang, Z.,
Hermanovski-Vosatka, A.,
Tu, Y.,
Cook, R. F.,
and Sargiacomo, M.
(1994)
J. Cell Biol.
126,
111-126 |
| 8. | Colombini, M. (1994) Curr. Top. Membr. 42, 73-101 |
| 9. | Benz, R. (1994) Biochim. Biophys. Acta 1197, 167-196[Medline] [Order article via Infotrieve] |
| 10. | Bàthori, G., Szabò, I., Schmehl, I., Tombola, F., Messina, A., De Pinto, V., and Zoratti, M. (1998) Biochem. Biophys. Res. Comm. 243, 258-263[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Huizing, M., Ruitenbeek, W., Thinnes, F. P., and De Pinto, V. (1994) Lancet 344, 762 |
| 12. |
Sampson, M. J.,
Lovell, R. S.,
and Craigen, W. J.
(1997)
J. Biol. Chem.
272,
18966-18973 |
| 13. |
Blachly-Dyson, E.,
Zambronicz, E. B., Yu, W. H.,
Adams, V.,
McCabe, E. R. B.,
Adelman, J.,
Colombini, M.,
and Forte, M.
(1993)
J. Biol. Chem.
268,
1835-1841 |
| 14. | Thinnes, F. P., Goetz, H., Kayser, H., Benz, R., Schmidt, W. E., Kratzin, H., and Hilschmann, N. (1989) Biol. Chem. Hoppe-Seyler 370, 1253-1264[Medline] [Order article via Infotrieve] |
| 15. | Kayser, H., Kratzin, H. D., Thinnes, F. P., Goetz, H., Schmidt, W. E., Eckart, K., and Hilschmann, N. (1989) Biol. Chem. Hoppe-Seyler 370, 1265-1278[Medline] [Order article via Infotrieve] |
| 16. |
Dermietzel, R.,
Hwang, T.-K.,
Buettner, R.,
Hofer, A.,
Dotzler, E.,
Kremer, M.,
Deutzmann, R.,
Thinnes, F. P.,
Fishman, G. I.,
Spray, D. C.,
and Siemen, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
499-503 |
| 17. | Jakob, C., Goetz, H., Hellmann, T., Hellmann, K. P., Reymann, S., Floerke, H., Thinnes, F. P., and Hilschmann, N. (1995) FEBS Lett. 368, 5-9[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Yu, W. H.,
Wolfgang, W.,
and Forte, M.
(1995)
J. Biol. Chem.
270,
13998-14006 |
| 19. |
Song, S. K.,
Li, S.,
Okamoto, T.,
Quilliam, L. A.,
Sargiacomo, M.,
and Lisanti, M. P.
(1996)
J. Biol. Chem.
271,
9690-9697 |
| 20. | De Pinto, V., Prezioso, G., and Palmieri, F. (1987) Biochim. Biophys. Acta 905, 499-502[Medline] [Order article via Infotrieve] |
| 21. | Bàthori, G., Szabò, I., Wolff, D., and Zoratti, M. (1996) J. Bioenerg. Biomembr. 28, 191-198[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Babel, D., Walter, G., Goetz, H., Thinnes, F. P., Juergens, L., Konig, U., and Hilschmann, N. (1991) Biol. Chem. Hoppe-Seyler 372, 1027-1034[Medline] [Order article via Infotrieve] |
| 23. | Winkelbach, H., Walter, G., Morys-Wortmann-C, Paetold, G., Hesse, D., Zimmermann, B., Florke, H., Reymann, S., Stadtmuller, U., Thinnes, F. P., and Hilschmann, N. (1994) Biochem. Med. Metab. Biol. 52, 120-127[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Cameron, P. L.,
Ruffin, J. W.,
Bollag, R.,
Rasmussen, H.,
and Cameron, R. S.
(1997)
J. Neurosci.
17,
9520-9535 |
| 25. |
Galbiati, F.,
Volonte', D.,
Gil, O.,
Zanazzi, G.,
Salzer, J. L.,
Sargiacomo, M.,
Scherer, P. E.,
Engelman, J. A.,
Schlegel, A.,
Parenti, M.,
Okamoto, T.,
and Lisanti, M. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
10257-10262 |
| 26. |
Scherer, P.,
Lisanti, M. P.,
Baldini, G.,
Sargiacomo, M.,
Corley Mastick, C.,
and Lodish, H. F.
(1994)
J. Cell Biol.
127,
1233-1243 |
| 27. | Thorp, K. M., Verschueren, H., De Baetselier, P., Southern, C., and Matthews, N. (1996) Immunology 87, 434-438[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | De Pinto, V., Benz, R., and Palmieri, F. (1989) Eur. J. Biochem. 183, 179-187[Medline] [Order article via Infotrieve] |
| 29. | Nobile, M., and Galietta, L. J. V. (1988) Biochem. Biophys. Res. Comm. 154, 719-726[CrossRef][Medline] [Order article via Infotrieve] |
| 30. | Pahapill, P. A., and Schlichter, L. C. (1992) J. Membr. Biol. 125, 171-183[Medline] [Order article via Infotrieve] |
| 31. | Lewis, T. M., Roberts, M. L., and Bretag, A. H. (1994) Neurosci. Lett. 181, 83-86[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Shoshan-Barmatz, V., Hadad, N., Fenf, W., Shafir, I., Orr, I., Varsanyi, M., and Heilmeyer, L. M. G. (1996) FEBS Lett. 386, 205-210[CrossRef][Medline] [Order article via Infotrieve] |
| 33. | Reymann, S., Haase, W., Krick, W., Burckhardt, G., and Thinnes, F. P. (1998) Pflügers Arch. Eur. J. Physiol. 436, 478-480[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Szabò, I.,
Bàthori, G.,
Tombola, F.,
Coppola, A.,
Schmehl, I.,
Brini, M.,
Ghazi, A.,
De Pinto, V.,
and Zoratti, M.
(1998)
FASEB J.
12,
495-502 |
| 35. | Kleene, R., Pfanner, N., Pfaller, R., Link, T. A., Sebald, W., Neupert, W., and Tropschug, M. (1987) EMBO J. 6, 2627-2633[Medline] [Order article via Infotrieve] |
| 36. | Larsson, N. G., Garman, J. D., Oldfors, A., Barsh, G. S., and Clayton, D. A. (1996) Nature Genetics 13, 296-302[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Oliva, M., Messina, A., Ragone, G., Caggese, C., and De Pinto, V. (1998) FEBS Lett. 430, 327-332[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Lithgow, T., Cuezva, J. M., and Silver, P. A. (1997) Trends Biochem. Sci. 22, 110-113[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Wigman, J. E.,
and Vale, R. D.
(1993)
J. Cell Biol.
123,
269-274 |
| 40. |
Gunkel, N.,
Yano, T.,
Markussen, F. H.,
Olsen, L. C.,
and Ephrussi, A.
(1998)
Genes Dev.
12,
1652-1664 |
| 41. | Freitag, H., Neupert, W., and Benz, R. (1982) Eur. J. Biochem. 123, 629-636[Medline] [Order article via Infotrieve] |
| 42. | Popp, B., Schmid, A., and Benz, R. (1995) Biochemistry 34, 3352-3361[CrossRef][Medline] [Order article via Infotrieve] |
| 43. |
Uittenbogaard, A.,
Ying, Y.,
and Smart, E. J.
(1998)
J. Biol. Chem.
273,
6525-6532 |
This article has been cited by other articles:
![]() |
V. Garg and K. Hu Protein kinase C isoform-dependent modulation of ATP-sensitive K+ channels in mitochondrial inner membrane Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H322 - H332. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lefebvre, F. Furt, M.-A. Hartmann, L. V. Michaelson, J.-P. Carde, F. Sargueil-Boiron, M. Rossignol, J. A. Napier, J. Cullimore, J.-J. Bessoule, et al. Characterization of Lipid Rafts from Medicago truncatula Root Plasma Membranes: A Proteomic Study Reveals the Presence of a Raft-Associated Redox System Plant Physiology, May 1, 2007; 144(1): 402 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Sabirov, T. Sheiko, H. Liu, D. Deng, Y. Okada, and W. J. Craigen Genetic Demonstration That the Plasma Membrane Maxianion Channel and Voltage-dependent Anion Channels Are Unrelated Proteins J. Biol. Chem., January 27, 2006; 281(4): 1897 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Szabo, J. Bock, A. Jekle, M. Soddemann, C. Adams, F. Lang, M. Zoratti, and E. Gulbins A Novel Potassium Channel in Lymphocyte Mitochondria J. Biol. Chem., April 1, 2005; 280(13): 12790 - 12798. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cohen, W. Schubert, D. L. Brasaemle, P. E. Scherer, and M. P. Lisanti Caveolin-1 Expression Is Essential for Proper Nonshivering Thermogenesis in Brown Adipose Tissue Diabetes, March 1, 2005; 54(3): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Riquelme, P. Llanos, E. Tischner, J. Neil, and B. Campos Annexin 6 Modulates the Maxi-chloride Channel of the Apical Membrane of Syncytiotrophoblast Isolated from Human Placenta J. Biol. Chem., November 26, 2004; 279(48): 50601 - 50608. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Okada, W. K. O'Neal, P. Huang, R. A. Nicholas, L. E. Ostrowski, W. J. Craigen, E. R. Lazarowski, and R. C. Boucher Voltage-dependent Anion Channel-1 (VDAC-1) Contributes to ATP Release and Cell Volume Regulation in Murine Cells J. Gen. Physiol., October 25, 2004; 124(5): 513 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Do, K. Peterson-Yantorno, C. H. Mitchell, and M. M. Civan cAMP-activated maxi-Cl- channels in native bovine pigmented ciliary epithelial cells Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1003 - C1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Sabirov and Y. Okada Wide Nanoscopic Pore of Maxi-Anion Channel Suits its Function as an ATP-Conductive Pathway Biophys. J., September 1, 2004; 87(3): 1672 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marmagne, M.-A. Rouet, M. Ferro, N. Rolland, C. Alcon, J. Joyard, J. Garin, H. Barbier-Brygoo, and G. Ephritikhine Identification of New Intrinsic Proteins in Arabidopsis Plasma Membrane Proteome Mol. Cell. Proteomics, July 1, 2004; 3(7): 675 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Baker, D. J. R. Lane, J. D. Ly, V. De Pinto, and A. Lawen VDAC1 Is a Transplasma Membrane NADH-Ferricyanide Reductase J. Biol. Chem., February 6, 2004; 279(6): 4811 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liu, Y. Ying, Y. Zhao, D. I. Mundy, M. Zhu, and R. G. W. Anderson Chinese Hamster Ovary K2 Cell Lipid Droplets Appear to Be Metabolic Organelles Involved in Membrane Traffic J. Biol. Chem., January 30, 2004; 279(5): 3787 - 3792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wandrey, B. Trevaskis, N. Brewin, and M. K. Udvardi Molecular and Cell Biology of a Family of Voltage-Dependent Anion Channel Porins in Lotus japonicus Plant Physiology, January 1, 2004; 134(1): 182 - 193. [Abstract] |